TipRanks
PYC Therapeutics Limited (PYCXF)
OTHER OTC:PYCXF
US Market
PYCXF
PYC Therapeutics Limited
RESEARCH TOOLSreports

PYC Therapeutics Limited (PYCXF) Income Statement

1 Followers

PYC Therapeutics Limited Income Statement

Last quarter (Q4 2026), PYC Therapeutics Limited's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, PYC Therapeutics Limited's net income was AU$-20.51M. See PYC Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 23.49MAU$ 22.06MAU$ 15.81MAU$ 16.04M
Gross Profit
AU$ -1.20MAU$ 23.49MAU$ 22.06MAU$ 14.92MAU$ 15.20M
Operating Expenses
AU$ 81.47MAU$ 77.12MAU$ 60.92MAU$ 39.16MAU$ 30.21M
Depreciation and Amortization
AU$ 1.20MAU$ 752.54KAU$ 1.07MAU$ 882.04KAU$ 839.50K
EBITDA
AU$ -81.47MAU$ -52.88MAU$ -54.55MAU$ -38.25MAU$ -29.39M
Operating Income
AU$ -82.67MAU$ -53.63MAU$ -38.86MAU$ -39.16MAU$ -30.21M
Other Income/Expenses
AU$ 12.91MAU$ 2.61MAU$ -16.81MAU$ 387.00AU$ -59.02K
Pretax Income
AU$ -69.76MAU$ -51.01MAU$ -55.67MAU$ -39.16MAU$ -30.27M
Net Income
AU$ -43.34MAU$ -50.30MAU$ -37.73MAU$ -22.79MAU$ -13.86M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.10AU$ >-0.01AU$ -0.01AU$ 0.00
Diluted EPS
AU$ -0.06AU$ -0.10AU$ >-0.01AU$ -0.01AU$ 0.00
Weighted Average Shares Outstanding
 732.56M 500.50M 3.93B 3.25B 3.22B
Weighted Average Shares Outstanding (Diluted)
 732.56M 500.50M 3.94B 3.25B 3.22B
Currency in AUD

PYC Therapeutics Limited Earnings and Revenue History